Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Leonel Barreto Gutierrez and Luc Kugener.
Leonel Barreto Gutierrez
Connection Strength
0.394
Luc Kugener
  1. SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy. Crit Care. 2020 10 22; 24(1):623.
    View in: PubMed
    Score: 0.057
  2. Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider. Crit Care. 2020 10 09; 24(1):603.
    View in: PubMed
    Score: 0.057
  3. TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction? Crit Care. 2020 10 06; 24(1):599.
    View in: PubMed
    Score: 0.057
  4. Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction? Crit Care. 2020 09 07; 24(1):551.
    View in: PubMed
    Score: 0.056
  5. Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure. Crit Care. 2020 08 04; 24(1):482.
    View in: PubMed
    Score: 0.056
  6. Inhibiting IL-6 in COVID-19: we are not sure. Crit Care. 2020 07 27; 24(1):463.
    View in: PubMed
    Score: 0.056
  7. Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation. Crit Care. 2020 06 16; 24(1):352.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.